Global Payer Evidence Lead/Director

Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger

Søborg

Are you interested in being a part of an organization that is dedicated to making a positive impact on people's lives? Are you passionate about optimizing market access and health technology assessment through payer-relevant evidence? Then Novo Nordisk might be the right place for you since we are now looking for a new Global Payer Evidence Lead/Director in Global Market Access & Pricing (GMAP). Join us for a life-changing career! The position As Global Payer Evidence Lead/Director, you will be accountable for driving the payer evidence strategy for a given therapy area as well as the execution and communication of evidence, thereby shaping the strategic direction for new assets. One of the key tasks is to build and maintain a comprehensive network of stakeholders with significant influence on payer evidence. Your role will also involve promoting learning and understanding of payer/HTA expectations, evidence requirements, and access needs. As a member of the Global Payer Evidence team, you will have the opportunity to work with some of the most innovative pipeline assets in Novo Nordisk’s history. The team is responsible for payer evidence strategy and long-term evidence planning across the portfolio. Key responsibilities:
  • Determine payer evidence strategy and tactics, support market access preparation for products in development and launch
  • Set evidence direction for Global Market Access team members, regions, and affiliates
  • Lead payer-relevant real-world evidence studies (incl. costed patient pathways, treatment patterns, patient preferences, and burden of illness)
  • Perform descriptive and statistical analyses from secondary data sources and manage ad-hoc evidence requests from affiliates to support payer dialogues and HTA submissions
  • Represent the payer view and GMAP in cross-functional evidence fora and processes
  • Anticipate and shape payer/HTA evidence requirements via publications and external engagement
  • Qualifications We are seeking a candidate with expertise in market access, health technology assessment (HTA), and real-world evidence (RWE), who can bring innovation and breakthrough thinking to our team. Your work will contribute to important decisions and milestones regarding pipeline evidence strategy across the portfolio. To be successful in this role, you should have:
  • M.Sc./Ph.D. degree in a relevant scientific field, e.g., outcomes research, epidemiology, economics
  • At least seven years of experience in market access and health outcomes research, ideally within the pharmaceutical industry or consultancy
  • Extensive experience working within market access and payer evidence, incl. RWE and HTA evidence requirements (current and emerging such as EUHTA), etc.
  • Direct experience in executing payer evidence studies
  • Good understanding of relevant methodologies and statistics for secondary database studies
  • Fluency in written and spoken English
  • On a personal level you have strong project and stakeholder management skills, as well as effective interpersonal communication skills. Additionally, you have a strategic and operational mindset, with a problem-solving approach that can identify solutions and influence decisions. Finally, strong skills in building productive relationships with internal and external stakeholders across key markets and functions are highly desirable. About the department GMAP is crucial to the commercial success of products in the pharmaceutical industry. This is your opportunity to join an international, high-performing team in Copenhagen, Denmark, working with bright people on some of the most innovative products in Novo Nordisk. Working at Novo Nordisk Novo Nordisk impacts millions of people across the world with a diverse portfolio. Your work will have an impact across our portfolio and therefore across the world. It is your skills, commitment, and ambitions that help us improve the lives of the patients. In return, we offer you the opportunity to work with talented colleagues in an ambitious and diverse environment and we commit dedication to your professional and personal development in order to help you realize your ambitions. Contact For further information please contact Mette Schrøder Hemels, VP of Global Payer Evidence at [email protected] Deadline 14th November 2023. Please note, that applications will be reviewed, and interviews will be conducted on an ongoing basis, so we encourage you to apply as soon as possible. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.


    Information og data

    Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".

    Arbejdsstedet er beliggende i Søborg.

    Jobbet er oprettet på vores service den 24.10.2023, men kan have været deaktiveret og genaktiveret igen.

    Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
    • Øvrige
    • Søborg

    Lignende jobs

    • Øvrige i København Ø

      Fri kontakt
      Senior Associates og Managere til Transaction Advisory Service i København. Vi mærker en stigende efterspørgsel efter rådgivning i forbindelse med køb og salg af virksomheder, herunder finansiel due diligence. Derfor søger vi Senior Associates og Managere til vores TAS team på Østerbro.
      • Øvrige
      • København Ø
      Få mere info
    • Øvrige i København K

      Fri kontakt
      Associate til IT Risk Assurance. Vi vækster i Grant Thorntons IT Risk Assurance & Advisory Services, og søger derfor en nyuddannet kollega. I afdelingen beskæftiger vi os med IT-revision, afgivelse af IT-erklæringer (ISAE 3402, ISAE 3000 mv.
      • Øvrige
      • København K
      Få mere info
    • Øvrige (praktik) i København

      Fri kontakt
      Ønsker du at prøve kræfter med en journalistisk arbejdsplads, hvor der er kort vej fra tanke til handling? Har du mod på at prøve dine kompetencer af i et idérigt miljø med høje krav til fagligheden? Og vil du være en del af en af Europas måske vigtigste virksomheder for retssikkerhed? Så er det dig, vi mangler! Om os.
      • Øvrige
      • København
      Få mere info
    • Øvrige i København

      Fri kontakt
      Ansøg senest: 12. juni 2024 København On-site. Er du ambitiøs og målrettet og god til at håndtere alverdens spørgsmål, så tror vi på, at du er vores nye Shiftleader på Scandic Spectrum. Vi ved, at du ta’r ansvar, har overblik og handler hurtigt, når det gælder.
      • Øvrige
      • København
      Få mere info

    Statistik over udbudte jobs som øvrige i Søborg

    Herunder ser du udviklingen i udbudte øvrige i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.

    Se flere statistikker her:
    Statistik over udbudte øvrige over tid

    Dato Alle jobs som øvrige
    19. maj 2024 70
    18. maj 2024 70
    17. maj 2024 73
    16. maj 2024 73
    15. maj 2024 74
    14. maj 2024 72
    13. maj 2024 66
    12. maj 2024 72
    11. maj 2024 72
    10. maj 2024 70
    9. maj 2024 73
    8. maj 2024 71
    7. maj 2024 68
    6. maj 2024 70
    5. maj 2024 70
    4. maj 2024 72
    3. maj 2024 75
    2. maj 2024 68
    1. maj 2024 77
    30. april 2024 82
    29. april 2024 81
    28. april 2024 79
    27. april 2024 78
    26. april 2024 80
    25. april 2024 78
    24. april 2024 78
    23. april 2024 82
    22. april 2024 84
    21. april 2024 85
    20. april 2024 87
    19. april 2024 86